Home
Sarepta Therapeutics SRPT paid Tarplin, Downs & Young $80K for lobbying in Q2 2023 · Budget, Health Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q2 2023
- Client
- Sarepta Therapeutics
- Reported
- 23/07/18
Up 0.0% from last quarter
What else happened in Sarepta Therapeutics around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Sarepta Therapeutics's other lobbying reports
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1